← Back to catalogue

ImmunoCAP Specific IgG, Antigen tp, Thyroid Peroxidase

FDA UDI

Class II (US FDA UDI)

by Phadia GmbH

Identity

Trade Name
ImmunoCAP Specific IgG, Antigen tp, Thyroid Peroxidase FDA UDI
Generic Name
Thyroid peroxidase antibody (anti-TPO/microsomal antibody) IVD, kit, fluorescent immunoassay FDA UDI
Device Name
ImmunoCAP Specific IgG, Antigen tp, Thyroid Peroxidase FDA UDI
Model / Reference
14-4508-01 FDA UDI
Description
ImmunoCAP Specific IgG, Antigen tp, Thyroid Peroxidase FDA UDI

Identifiers

Catalog Number
14-4508-01 FDA UDI
Primary DI / UDI-DI
07333066004013 FDA UDI
510(k) Number
K072661 FDA UDI
FDA Product Code
JZO FDA UDI
GMDN Term
Thyroid peroxidase antibody (anti-TPO/microsomal antibody) IVD, kit, fluorescent immunoassay FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.5870 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Thyroid peroxidase antibody (anti-TPO/microsomal antibody) IVD, kit, fluorescent immunoassay

ImmunoCAP Specific IgG, Antigen tp, Thyroid Peroxidase by Phadia GmbH — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Thyroid peroxidase antibody (anti-TPO/microsomal antibody) IVD, kit, fluorescent immunoassay.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Phadia GmbH

Sources (1)

  • FDA UDI 0352aab8-8378-4a4d-93bb-cfd48cfa1ae3 37 fields · synced Jun 6, 2026